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ABSTRACT
This report was based on the data from the Renal Registry of the Hospital Authority of Hong Kong,
accounted for 90% to 95% of all the patients on renal replacement therapy (RRT) in Hong Kong.
Patients who received RRT under the private sectors were not included in this report. The data
were as of 31 March 1999.
There were 11 renal units, five satellite centers and four major renal transplant centers. The number
of patients on RRT was 4268 [627 patients per million (pmp)], of which 58% (2490 patients, 360
pmp) were on peritoneal dialysis (PD), 13% (576 patients, 85 pmp) on hemodialysis (HD) and 28%
(1202 patients, 177 pmp) with functioning kidney transplants (TX). The net increase of the number
of patients on RRT from previous year was 10%. The incidence of end-stage renal failure was 762
(112 pmp). The median age of the existing patients on RRT was 52, of which 33% were above the
age of 61 years. The median age of the new patients was 56 years, of which 50% were above the
age of 61 years. The major causes of renal failure for existing patients were glomerulonephritis
32%, unknown 26% and diabetes 21%. For the new cases, 34% were due to diabetic nephropathy.
Of all the patients on RRT, 10% were serologically positive for hepatitis B infection while 6% were
positive for hepatitis C infection.
Of all the patients on dialysis, 81% were on PD, of which 92% were on continuous ambulatory
peritoneal dialysis (CAPD). Of the CAPD patients, 13% were still using "connect" systems, 75%
were using "disconnect" systems and 12% using UV flash systems. Nineteen percent of all the
patients on dialysis were on HD, of which 54% were on hospital based HD, 21% on satellite center
based HD, 9% on charitable center based HD and 3% on home HD. Of the 1202 patients with
kidney transplants, 629 (52%) were transplanted in Hong Kong. Of these, 325 (52%) were cadaveric
kidney transplantation. For the year ending 31 March 1999, 113 patients (17 pmp) received a
kidney transplantation, of which 58 transplants were performed in Hong Kong (30 cadaveric kidneys
and 28 living related kidneys). Thirty-one percent of all the patients on RRT were receiving
erythropoietin therapy.
The annual crude mortality rate for all RRT was 7% (8% for PD, 14% for HD and 1.6% with TX). The
major causes of death were cardiovascular (24%), infection (22%) and cerebral vascular accident
(6%). The 1 and 5 year patient survivals for kidney transplants performed in Hong Kong between
1 April 1993 to 31 March 1998 were 98%, 96% for living related kidney and 94%, 89% for cadaveric
kidney. The 1 and 5 year graft survivals were 92%, 88% (censored), 91%, 85% (not censored) for
living related kidney and 89%, 83% (censored), 86%, 79% (not censored) for cadaveric kidney. The
overall peritonitis rate for all CAPD systems for the 7 months ending 31 March 1999 was one
episode per 21 months. The peritonitis rate of the new disconnect systems was one episode per 20
to 27 months.
The point prevalence rate of RRT (1997 data) for Hong Kong was within 15% range of that for
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Australia, Canada and most European countries, but only 40% to 60% of that for Japan, USA and
Taiwan. The percentage of dialysis patients being treated with PD was highest in the world.
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INTRODUCTION
This Renal Registry Report was based on the data from
the Renal Registry of the Hospital Authority, Hong Kong.
It accounted for approximately 90% to 95% of all the
patients on renal replacement therapy (RRT) in Hong
Kong. Patients who received RRT under the private
sectors were not included in this report. The data were
as of 31 March 1999.
THE RENAL REGISTRY/CLINICAL
INFORMATION SYSTEM OF
HONG KONG
The Renal Registry implemented by the Hospital
Authority of Hong Kong on 1 April 1995 is a new type
of direct on-line computerized registry. Computer
terminals installed at all renal units operated by the
Hospital Authority are linked by cable network system
to a central database at head office. Data are entered
directly into the local computer terminals. There is no
need to fill in manual annual report forms.
The Renal Registry is a computerized clinical
information system, which can be used by individual
renal unit as a database for clinical management and
direct on-line data analysis. As all the data are stored in
the central server, it allows Head Office to compile
registry report for the whole of Hong Kong.
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The Renal Registry is linked with other related
computerized systems. It allows automatic download of
1. donor's data from the "Organ Procurement System"
used by the Transplant Co-ordinator and 2. individual
HLA data from the "Tissue Typing Laboratory System".
A steering committee determined the list of relevant data
to be collected for the Hong Kong Registry. An
implementation team consisted of nephrologists and staff
from Information Technology Division of the Hospital
Authority jointly designed, developed and implemented
the system. The success in the system was mainly due
to: 1. the development of the concept of a functional
clinical information system with the renal registry report
as a by-product; 2. on-site direct data entry; 3. ownership
and accessibility of the data by individual unit; and 4.
the combined team work between the clinicians and the
IT team, making use of the latest advances in computer
technology.
The registry has the potential  of  being very
comprehensive, yet flexible in the way and the amount
of data being collected. The collection of key data was
made compulsory by the Central Renal Committee. The
collection of non-essential data was optional for
individual renal units.
PROVISION OF RENAL SERVICE
IN HONG KONG
Approximately 90% to 95% of the RRT were provided
by the Hospital Authority of Hong Kong, a statutory
Government body responsible for the provision of
secondary/tertiary health service in Hong Kong. The
remaining 5% to 10% of the RRT were provided by the
private sector and charitable organizations.
There were 11 renal units and five satellite centers [2.4
unit per million population (pmp)] operated by the
Hospital Authority. There were 177 hemodialysis
machines, of which 15 were earmarked for patients with
hepatitis B infection. There were four major renal
transplant centers. Two other centers also performed
some renal transplantation.
PREVALENCE AND INCIDENCE
OF RENAL REPLACEMENT
THERAPY
As of 31 March 1999, 4268 patients (627 pmp) were on
RRT, of which 58% (n = 2490, 366 pmp) were on
peritoneal dialysis (PD), 13% (n = 576, 85 pmp) on
hemodialysis (HD) and 29% (n = 1202, 177 pmp) with
functioning kidney transplants (TX). The net increase
of number of patients on RRT from previous year was
10%.
For the year ending 31 March 1999, 762 new patients
required RRT, of which 691 were commenced on PD,
50 on HD and 21 had kidney transplantation (without
prior dialysis treatment at any renal unit of the Hospital
Authority). For the same period, the total number of
patients who had received kidney transplantation in or
outside Hong Kong was 113.
The increasing trend of the prevalence and incidence of
RRT and for the different types of RRT were as shown
in figures 1 and 2.
AGE AND GENDER
The median age of all the patients on RRT was 52 years
(HD 51, PD 59, TX 43). Of the patients, 33% were above
the age of 61 years and 9% above the age of 71 years.
The age distribution was as shown in figure 3.
Figure 1. Point prevalence (as of 31 March of each year) and
incidence (for 12 months ending 31 March of each year) of renal
replacement therapy (RRT).
Figure 2. Point prevalence (as of 31 March of each year) of the
different modes of renal replacement therapy. (PD = Peritoneal
Dialysis; HD = Hemodialysis; Tx = Transplant).
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The median age of all the new patients commenced on
RRT for year ending 31 March 1999 was 61 years (HD
54, PD 62, TX 38). Of the new patients, 50% were above
the age of 61 years and 17% above the age of 71 years.
The age distribution was as shown in figure 4.
The median age of the patients on RRT and new patients
commenced on RRT increased by 5 years for the past 4
years.
Of all the patients on RRT, the ratio of male to female
was 53 to 47 (49:51 for PD, 56:44 for HD and 59:41 for
TX).
PRIMARY RENAL DISEASE
The causes of renal failure for all the patients on RRT
and for the new patients entered into the RRT program
was as shown in table 1.
The prevalence of diabetic nephropathy increased from
13% in 1995 to 21% in 1999. The number of patients
presenting with diabetic nephropathy increased from
28% in 1996 to 34% in 1999.
Of the glomerulonephritis (GN), 47% were primary GN,
10% were secondary GN, 5% were advanced sclerosing
GN and 38% had suspected of GN but not proven by
biopsy. Of all the biopsy proven primary GN, 54% were
I g A n e p h r o p a t h y,  1 5 %  f o c a l  s e g m e n t a l
glomerulosclerosis, 7% mesangial-capillary GN, 7%
membranous GN and 5% crescentic GN. The main cause
of secondary GN was systemic lupus erythematous
(75%).
COMORBID RISK FACTORS
Hepatitis B and C Infection
Of all the patients on RRT, 10% were serologically
positive for hepatitis B infection (PD 11%, HD 9%, TX
9%), 6% were positive for hepatitis C infection (PD 3%,
HD 12%, TX 8%). The trend of hepatitis B and C
infection over the past 5 years were as shown in figures
5 and 6.
Diabetes Mellitus
Twenty-three percent of all the patients on RRT were
Figure 3. Age distribution of all patients on RRT (cumulative of
different modes of RRT) as of 31 March 1999.
Figure 4. Age distribution of all new patients on RRT (cumulative
of different modes of RRT) for 12 months ending 31 March 1999
(** for new transplant cases).
Table 1. Primary underlying renal disease for all patients as of 31
March 1999 and for new patients for the 12 months ending 31
March 1999 (GN = Glomerulonephritis; DM = Diabetes mellitus).
Primary renal disease Existing patients    New patients
GN 32% 27%
Infection/reflux 3% 1%
Inherited/congenital 4% 3%
Obstructive/urolithiasis 4% 3%
Hypertensive/vascular 5% 8%
DM 21% 34%
Others 4% 3%
Unknown (ESRF) 26% 20%
Figure 5. Comorbidity - Hepatitis B infection (as of 31 March of
each year).
TX
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diabetics (PD 32%, HD 14%, TX 8%). The growing trend
of patients with diabetes was as shown in figure 7.
RENAL REPLACEMENT THERAPY
Peritoneal Dialysis
Eighty-one percent of the patients requiring RRT were
on PD. Of these 2490 patients (366 pmp) maintained on
PD, 2312 (92%) were on continuous ambulatory
peritoneal dialysis (CAPD) and 100 (4%) were on night
intermittent peritoneal dialysis (NIPD) or continuous
cyclic peritoneal dialysis (CCPD). The net increase in
the number of patients maintained on PD from previous
year was 274 (+12%). The growing trend of the number
of patients supported by PD was as shown in figure 8.
Only 13% of the patients on CAPD were on connect
systems, 75% were on disconnecting systems and 12%
on UV flash systems.
All new patients requiring RRT were commenced on
CAPD unless there were contraindications to do so. The
funding of the dialysis fluid was mainly by Hospital
Authority (96%). About 1% of the CAPD fluid was
supported by charitable funds.
Hemodialysis
There were 576 patients (85 pmp) on HD, of which 309
(54%) were on hospital based HD, 121 (21%) on satellite
center based HD, 54 (9%) on charitable center based HD
and 15 (3%) on home HD. The net increase in the number
of patients on HD from previous year was 38 (+7%).
The growing trend of the number of patients supported
by HD was as shown in figure 9.
Majority of the patients commenced on HD were
transferred from other modes of therapy, in particular
following failure of CAPD treatment.
Hospital based and satellite HD were funded by The
Government via the Hospital Authority. Patients were
only required to pay a small amount of hospital
attendance fee. Patients receiving HD at charitable
centers paid for their own HD at a subsidized rate.
Figure 6. Comorbidity - Hepatitis C infection (as of 31 March of
each year).
Figure 7. Comorbidity - Diabetes Mellitus (as of 31 March of each
year).
Figure 8. The number of patients on PD (as of 31 March of each
year).
Figure 9. The number of patients on HD (as of 31 March of each
year).
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Patients receiving HD at private centers were not
included in this report.
Kidney Transplantation
There were 1202 patients (177 pmp) with a functioning
kidney graft, of which 629 (52%) were transplanted in
Hong Kong. The others were performed overseas. Of all
the kidney transplants performed in Hong Kong, 325
(52%) were cadaveric kidney transplantation and 304
were living related kidney transplantation. The growing
trend of the number of patients with transplant was as
shown in figures 10 and 11.
For the year ending 31 March 1999, 113 patients (17
pmp) received kidney transplantation. Of these, 58
transplants were performed in Hong Kong (30 were with
cadaveric kidneys and 28 with living related kidneys).
The other 55 patients received transplants overseas. The
number of transplants performed over the past 18 years
was as shown in figure 12.
Erythropoietin
Thirty-one percent of all the patients on RRT (976
patients, 143 pmp) received erythropoietin therapy, an
increase of 8% from the previous year. Twenty-six
percent of all the patients on PD versus 56% of all the
patients on HD were on erythropoietin. The growing
trend of the number of patients treated with erythropoietin
was as shown in figure 13.
Figure 10.  The number of patients with transplants performed in
and outside Hong Kong (as of 31 March of each year).
Figure 11.  The number of patients with cadaveric and living related
transplants performed in Hong Kong (as of 31 March of each year).
Figure 12.  The number of cadaveric and living related transplants
performed in Hong Kong and outside Hong Kong (for the year
ending 31 December).
Figure 13.  The number of patients treated with erythropoietin (as
of 31 March of each year).
Table 2. Cause of death (%) for the 12 months ending 31 March
1999.
PD HD TX All
Cardiovascular 21 32 16 24
Cerebrovascular 6 8 0 6
Liver failure 1 3 0 1
Infection 25 13 21 22
Malignancy 5 1 16 5
Termination 5 6 0 5
Others 19 17 31 19
Unknown 18 20 16 18
Total number 210 78 19 307
Mortality rate 8% 14% 1.6% 7%
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Table 3. Comparison of worldwide renal registry data (Dx =
Dialysis).
HK SIN TAI JAP AUS CAN USA GER
Year (pmp) 97  97 97 97 97 97 97 96
RRT (pmp) 587 NA 1013 1397 530 690 1131 683
Rate (pmp/yr) 113 158 316 229 79 116 296 153
Tx (pmp) 168 NA NA 41 252 299 323 161
Rate (pmp/yr) 10 NA NA 1 28 32 45 42
% of RRT 29 NA NA 5 47 43 27 23
Dx (pmp) 411 646 NA 1356 278 391 808 522
CAPD%  80 17 NA 5 32 29 12 7
HD and 1.6% with TX). The trend of mortality rate was
as shown in figure 14. The causes and the trend of death
were as shown in table 2 and figure 15. The main causes
of death were cardiovascular (24%) and infection (22%).
Transplant Survival Rates
For living related kidney transplants performed in Hong
Kong between 1 April 1993 and 31 March 1998, 1 and 5
year patient survivals were 98% and 96% respectively.
One and 5 year graft survivals were 92% and 88%
(censored) and 91% and 85% (not censored).
For cadaveric related kidney transplants performed in
Hong Kong between 1 April 1993 and 31 March 1998, 1
and 5 year patient survivals were 94% and 89%. One
and 5 year graft survivals were 89% and 83% (censored)
and 86% and 79% (not censored). These data were as
shown in figures 16 and 17.
OUTCOME INDICATORS
Crude Mortality Rates and Cause of Death
The mortality rate was defined as the mortality rate of
all patients treated during the period of the report. The
annual crude mortality rate for year ending 31 March
1999 for all modes of RRT was 7% (8% for PD, 14% for
Figure 15.  The major causes of death for the 12 months ending
31 March of each year.
Figure 16.  One to 5 year graft survivals for transplants performed
in Hong Kong between 1 April 1993 and 31 March 1998 (LR =
Living related; Cad = Cadaveric; C = Censored; NC = Not
censored).
Figure 14.  The annual crude mortality rate (for the 12 months
ending 31 March of each year).
Figure 17.  One to 5 year patient survivals for transplants performed
in Hong Kong between 1 April 1993 and 31 March 1998 (LR =
Living related; Cad = Cadaveric; on TX = While with transplant; Hx
TX = With history of transplant).
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Peritonitis Rate
The overall peritonitis rate for all CAPD systems for the
7 months ending 31 March 1999 was one episode per 21
months. The peritonitis rate for different systems was:
Baxter spike system had one in 14, Ultraset one in 25,
Ultrabag one in 27, UV flash one in 17, UVXD one in
11, Fresenius conventional one in 14 and Stay-safe one
in 20.
COMPARISON OF WORLDWIDE
1997 DATA
The point prevalence rate of 587 pmp for Hong Kong in
1997 was 9% greater than that for Australia, 15% less
than that for Canada and most European countries and
was only 40% to 60% of that for Japan, USA and Taiwan
(Table 3).
The incidence rate of 113 pmp per year for Hong Kong
was greater than that for Australia, similar to Canada
and was only 35% to 49% of that for Taiwan, USA and
Japan.
The percentage of dialysis patients being treated with
PD was 81%, which was the highest in the world.
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